Heterogeneity of case definitions used in vaccine effectiveness studies—And its impact on meta-analysis

In the literature, different definitions of clinical illness cases and observation period are used to assess influenza vaccine effectiveness, usually without addressing their actual specificity and sensitivity. These properties, however, have large implications on influenza vaccine effectiveness est...

Full description

Saved in:
Bibliographic Details
Published inVaccine Vol. 24; no. 44; pp. 6602 - 6604
Main Author Beyer, Walter E.P.
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Ltd 10.11.2006
Elsevier
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In the literature, different definitions of clinical illness cases and observation period are used to assess influenza vaccine effectiveness, usually without addressing their actual specificity and sensitivity. These properties, however, have large implications on influenza vaccine effectiveness estimates in single trials and meta-analyses of trials. Re-arranging 30 trials (in 17 publications) with a total of 29,265 subjects according to specificity and sensitivity of their case definitions and observation periods, resulted in large differences between vaccine effectiveness estimates for various levels of specificity and sensitivity. For highly specific definitions the combined vaccine effectiveness estimate was 54%, but for highly sensible definitions only 11%. Such findings call for a cautious interpretation of combined vaccine effectiveness estimates. Internationally agreed case and observation period definitions would be desirable to facilitate future meta-analyses.
AbstractList In the literature, different definitions of clinical illness cases and observation period are used to assess influenza vaccine effectiveness, usually without addressing their actual specificity and sensitivity. These properties, however, have large implications on influenza vaccine effectiveness estimates in single trials and meta-analyses of trials. Re-arranging 30 trials (in 17 publications) with a total of 29,265 subjects according to specificity and sensitivity of their case definitions and observation periods, resulted in large differences between vaccine effectiveness estimates for various levels of specificity and sensitivity. For highly specific definitions the combined vaccine effectiveness estimate was 54%, but for highly sensible definitions only 11%. Such findings call for a cautious interpretation of combined vaccine effectiveness estimates. Internationally agreed case and observation period definitions would be desirable to facilitate future meta-analyses.
In the literature, different definitions of clinical illness cases and observation period are used to assess influenza vaccine effectiveness, usually without addressing their actual specificity and sensitivity. These properties, however, have large implications on influenza vaccine effectiveness estimates in single trials and meta-analyses of trials. Re-arranging 30 trials (in 17 publications) with a total of 29,265 subjects according to specificity and sensitivity of their case definitions and observation periods, resulted in large differences between vaccine effectiveness estimates for various levels of specificity and sensitivity. For highly specific definitions the combined vaccine effectiveness estimate was 54%, but for highly sensible definitions only 11%. Such findings call for a cautious interpretation of combined vaccine effectiveness estimates. Internationally agreed case and observation period definitions would be desirable to facilitate future meta-analyses.In the literature, different definitions of clinical illness cases and observation period are used to assess influenza vaccine effectiveness, usually without addressing their actual specificity and sensitivity. These properties, however, have large implications on influenza vaccine effectiveness estimates in single trials and meta-analyses of trials. Re-arranging 30 trials (in 17 publications) with a total of 29,265 subjects according to specificity and sensitivity of their case definitions and observation periods, resulted in large differences between vaccine effectiveness estimates for various levels of specificity and sensitivity. For highly specific definitions the combined vaccine effectiveness estimate was 54%, but for highly sensible definitions only 11%. Such findings call for a cautious interpretation of combined vaccine effectiveness estimates. Internationally agreed case and observation period definitions would be desirable to facilitate future meta-analyses.
Author Beyer, Walter E.P.
Author_xml – sequence: 1
  givenname: Walter E.P.
  surname: Beyer
  fullname: Beyer, Walter E.P.
  email: wbeyer@planet.nl
  organization: National Influenza Centre, Department of Virology, Erasmus Medical Centre, P.O. Box 1738, NL-3000 DR Rotterdam, The Netherlands
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18284842$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/16797799$$D View this record in MEDLINE/PubMed
BookMark eNqNktGKEzEUhoOsuN3VR1ACongzNZmZTBJEZFnUFRa8UfAupJkTSZ1mak6m0Dsfwif0SUxtVeiF9Sq5-P7_5OT_L8hZHCMQ8pCzOWe8e76cb6xzIcK8ZqybMzFnjbpDZlzJpqoFV2dkxuqurVrOPp2TC8QlY0w0XN8j57yTWkqtZyTcQIY0foYIIW_p6KmzCLQHH2LIYYxIJ4SehkgP8yh4Dy6HTZEgUsxTHwB_fPt-FQuWkYbV2rpMx0hXkG1lox22GPA-uevtgPDgcF6Sj29ef7i-qW7fv313fXVbOdHoXMladkoxD41SC8uglsLW1pabVaJvhGpk3QnGtO-ltF5o66TwiwV4Jsvq0FySp3vfdRq_ToDZrAI6GAYbYZzQdIq3LevakyDXjWaiFQV89m-wPEfKTna6oI-P0OU4pfIDO0poJnX7i3p0oKbFCnqzTmFl09b8jqUATw6ARWcHn2x0Af9yqlatauvCvdhzLo2ICbxxIdtdbDnZMBjOzK4sZmkO4ZldWQwTppSlqMWR-s-AE7pXex2UGDcBkkEXIDroQyrNMP0YTjq8PHJwQ-lbWfULbP9D_xMm9vEq
CODEN VACCDE
CitedBy_id crossref_primary_10_1016_j_vaccine_2014_07_101
crossref_primary_10_1136_ebn1064
crossref_primary_10_1371_journal_pone_0236041
crossref_primary_10_1016_j_vaccine_2008_07_048
crossref_primary_10_1080_14760584_2023_2262563
crossref_primary_10_1093_ije_dym021
crossref_primary_10_1186_s12916_014_0244_9
crossref_primary_10_3390_vaccines12020136
crossref_primary_10_1016_j_vaccine_2007_08_063
crossref_primary_10_1186_s12879_016_1532_0
crossref_primary_10_1016_j_jviromet_2016_02_005
crossref_primary_10_1016_j_prevetmed_2013_10_017
crossref_primary_10_1007_BF03404072
crossref_primary_10_1086_595842
crossref_primary_10_1016_j_vaccine_2013_08_056
crossref_primary_10_1186_s12916_015_0295_6
crossref_primary_10_1016_S0140_6736_06_69713_4
crossref_primary_10_2807_1560_7917_ES_2019_24_45_1900140
crossref_primary_10_1093_cid_cit580
crossref_primary_10_1016_j_vaccine_2008_07_022
Cites_doi 10.1001/jama.282.2.137
10.1016/S0264-410X(99)00332-1
10.1016/j.vaccine.2004.01.068
10.1016/0197-2456(86)90046-2
10.1016/j.virusres.2004.02.005
ContentType Journal Article
Copyright 2006 Elsevier Ltd
2007 INIST-CNRS
Copyright Elsevier Limited Nov 10, 2006
Copyright_xml – notice: 2006 Elsevier Ltd
– notice: 2007 INIST-CNRS
– notice: Copyright Elsevier Limited Nov 10, 2006
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7RV
7T2
7T5
7U9
7X7
7XB
88C
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9-
K9.
KB0
LK8
M0R
M0S
M0T
M1P
M2O
M7N
M7P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
DOI 10.1016/j.vaccine.2006.05.038
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Nursing & Allied Health Database
Health and Safety Science Abstracts (Full archive)
Immunology Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Healthcare Administration Database (Alumni)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest SciTech Premium Collection Natural Science Collection Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
AIDS and Cancer Research Abstracts
SciTech Premium Collection
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Biological Science Collection
Consumer Health Database
ProQuest Health & Medical Collection
Healthcare Administration Database
Medical Database
ProQuest Research Library
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Health Management (Alumni Edition)
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Research Library
Health & Safety Science Abstracts
ProQuest Public Health
ProQuest Central Basic
ProQuest Health Management
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
ProQuest Medical Library
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Research Library Prep
AIDS and Cancer Research Abstracts
MEDLINE
MEDLINE - Academic

AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Veterinary Medicine
Biology
Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-2518
EndPage 6604
ExternalDocumentID 3420764391
16797799
18284842
10_1016_j_vaccine_2006_05_038
S0264410X06006025
Genre Meta-Analysis
Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
29Q
4.4
457
4G.
53G
5RE
5VS
7-5
71M
7RV
7X7
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8P~
9JM
AAAJQ
AABNK
AAEDT
AAEDW
AAHBH
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABFRF
ABJNI
ABKYH
ABMAC
ABMZM
ABRWV
ABUWG
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACPRK
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
ADMUD
ADNMO
ADVLN
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEUYN
AEVXI
AEXOQ
AFJKZ
AFKRA
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGCQF
AGEKW
AGGSO
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
AQUVI
ASPBG
AVWKF
AXJTR
AZFZN
AZQEC
BBNVY
BENPR
BHPHI
BKEYQ
BKNYI
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
CCPQU
CJTIS
CNWQP
CS3
DWQXO
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
FYUFA
G-2
G-Q
GBLVA
GNUQQ
GUQSH
HCIFZ
HEJ
HLV
HMCUK
HMG
HMK
HMO
HVGLF
HX~
HZ~
IHE
J1W
K9-
KOM
L7B
LK8
LUGTX
LW9
M0R
M0T
M1P
M29
M2O
M41
M7P
MO0
N9A
NAPCQ
O-L
O9-
O9~
OAUVE
OK0
OZT
P-8
P-9
P2P
PC.
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PUEGO
Q38
R2-
ROL
RPZ
SAB
SAE
SCC
SDF
SDG
SDP
SES
SEW
SIN
SNL
SPCBC
SSH
SSI
SSZ
SVS
T5K
UKHRP
UV1
WH7
WOW
WUQ
XPP
Z5R
ZGI
ZXP
~G-
3V.
AACTN
AAIAV
ABLVK
ABYKQ
AESVU
AFCTW
AFKWA
AJBFU
AJOXV
AMFUW
EFLBG
LCYCR
QYZTP
RIG
AAYXX
ACMHX
ADSLC
AGRNS
AGWPP
ALIPV
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T2
7T5
7U9
7XB
8FK
C1K
H94
K9.
M7N
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
ID FETCH-LOGICAL-c539t-7276880fe388ba0e275a2aaa0ea85d35837265009fd77af59ac75fbbef07873e3
IEDL.DBID 7X7
ISSN 0264-410X
IngestDate Thu Aug 07 14:47:37 EDT 2025
Fri Jul 11 10:21:43 EDT 2025
Fri Jul 11 02:16:49 EDT 2025
Wed Aug 13 07:11:04 EDT 2025
Wed Feb 19 01:45:43 EST 2025
Mon Jul 21 09:16:06 EDT 2025
Thu Apr 24 23:06:52 EDT 2025
Tue Jul 01 03:44:53 EDT 2025
Fri Feb 23 02:32:28 EST 2024
Tue Aug 26 16:34:22 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 44
Keywords Specificity
Sensitivity
Influenza vaccine
Vaccine effectiveness
Meta-analysis
Infection
Viral disease
Influenza
Vaccine
Metaanalysis
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c539t-7276880fe388ba0e275a2aaa0ea85d35837265009fd77af59ac75fbbef07873e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
PMID 16797799
PQID 1559079469
PQPubID 23462
PageCount 3
ParticipantIDs proquest_miscellaneous_68144064
proquest_miscellaneous_19390545
proquest_miscellaneous_1500776769
proquest_journals_1559079469
pubmed_primary_16797799
pascalfrancis_primary_18284842
crossref_citationtrail_10_1016_j_vaccine_2006_05_038
crossref_primary_10_1016_j_vaccine_2006_05_038
elsevier_sciencedirect_doi_10_1016_j_vaccine_2006_05_038
elsevier_clinicalkey_doi_10_1016_j_vaccine_2006_05_038
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2006-11-10
PublicationDateYYYYMMDD 2006-11-10
PublicationDate_xml – month: 11
  year: 2006
  text: 2006-11-10
  day: 10
PublicationDecade 2000
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: Netherlands
– name: Kidlington
PublicationTitle Vaccine
PublicationTitleAlternate Vaccine
PublicationYear 2006
Publisher Elsevier Ltd
Elsevier
Elsevier Limited
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
– name: Elsevier Limited
References Nichol, Mendelman (bib3) 2004; 103
DerSimonian, Laird (bib5) 1986; 7
Nichol (bib4) 1999; 282
Villari, Manzoli, Boccia (bib2) 2004; 22
Demicheli, Jefferson, Rivetti, Deeks (bib1) 2000; 18
Villari (10.1016/j.vaccine.2006.05.038_bib2) 2004; 22
Nichol (10.1016/j.vaccine.2006.05.038_bib3) 2004; 103
Demicheli (10.1016/j.vaccine.2006.05.038_bib1) 2000; 18
DerSimonian (10.1016/j.vaccine.2006.05.038_bib5) 1986; 7
Nichol (10.1016/j.vaccine.2006.05.038_bib4) 1999; 282
References_xml – volume: 103
  start-page: 3
  year: 2004
  end-page: 8
  ident: bib3
  article-title: Influence of clinical case definitions with varying levels of sensitivity and specificity on estimates of the relative and absolute health benefits of influenza vaccination and implications for economic analyses
  publication-title: Virus Res
– volume: 22
  start-page: 3475
  year: 2004
  end-page: 3486
  ident: bib2
  article-title: Methodological quality of studies and patient age as major sources of variation in efficacy estimates of influenza vaccination in healthy adults: a meta-analysis
  publication-title: Vaccine
– volume: 282
  start-page: 137
  year: 1999
  end-page: 144
  ident: bib4
  article-title: Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults
  publication-title: J Am Med Assoc
– volume: 7
  start-page: 177
  year: 1986
  end-page: 188
  ident: bib5
  article-title: Meta-analysis in clinical trials
  publication-title: Contr Clin Trials
– volume: 18
  start-page: 957
  year: 2000
  end-page: 1030
  ident: bib1
  article-title: Prevention and early treatment of influenza in healthy adults
  publication-title: Vaccine
– volume: 282
  start-page: 137
  year: 1999
  ident: 10.1016/j.vaccine.2006.05.038_bib4
  article-title: Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults
  publication-title: J Am Med Assoc
  doi: 10.1001/jama.282.2.137
– volume: 18
  start-page: 957
  year: 2000
  ident: 10.1016/j.vaccine.2006.05.038_bib1
  article-title: Prevention and early treatment of influenza in healthy adults
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(99)00332-1
– volume: 22
  start-page: 3475
  year: 2004
  ident: 10.1016/j.vaccine.2006.05.038_bib2
  article-title: Methodological quality of studies and patient age as major sources of variation in efficacy estimates of influenza vaccination in healthy adults: a meta-analysis
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2004.01.068
– volume: 7
  start-page: 177
  year: 1986
  ident: 10.1016/j.vaccine.2006.05.038_bib5
  article-title: Meta-analysis in clinical trials
  publication-title: Contr Clin Trials
  doi: 10.1016/0197-2456(86)90046-2
– volume: 103
  start-page: 3
  year: 2004
  ident: 10.1016/j.vaccine.2006.05.038_bib3
  article-title: Influence of clinical case definitions with varying levels of sensitivity and specificity on estimates of the relative and absolute health benefits of influenza vaccination and implications for economic analyses
  publication-title: Virus Res
  doi: 10.1016/j.virusres.2004.02.005
SSID ssj0005319
Score 1.9293958
SecondaryResourceType review_article
Snippet In the literature, different definitions of clinical illness cases and observation period are used to assess influenza vaccine effectiveness, usually without...
SourceID proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 6602
SubjectTerms Applied microbiology
Biological and medical sciences
Estimates
Fundamental and applied biological sciences. Psychology
Heterogeneity
Humans
Illnesses
Immunization
Influenza
Influenza vaccine
Influenza Vaccines - immunology
Influenza Vaccines - therapeutic use
Influenza, Human - epidemiology
Influenza, Human - prevention & control
Meta-analysis
Microbiology
Randomized Controlled Trials as Topic - standards
Respiratory diseases
Seasons
Sensitivity
Specificity
Studies
Treatment Outcome
Vaccine effectiveness
Vaccines
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
Winter
SummonAdditionalLinks – databaseName: Elsevier SD Freedom Collection Journals [SCFCJ]
  dbid: AIKHN
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fi9QwEB_OOxRBRNd_1fOMIPd03Q1NkzaPy-GxKncceCf7VtI2gR7aLrYr3Jsfwk_oJ3HSpFsOXE58K-kMJM10ZpL5zQzAO2ETGjVlYamoCuMyYWFuijg0EdqKBH0IreyF_umZWFzGH5d8uQPHQy6MhVV63e90eq-t_cjMf83Zqqpmn2lvy-mSCltUJOJ3YC9iUqBo780_fFqcjUgP1vf3sPShZRgTeWZX0x-qsBFsH5bgU2ozVf5uoh6sVIsfzriOF9td0t40nTyCh96nJHM37cewo-sJ3HVdJq8ncO_Ux88ncHjuKlVfH5GLMfGqPSKH5HysYY08ky8WJtPn6pKB_QlUCzvaoMxpdN5JY0iBRpCU2lS1g36RdatLUtXEL5g4vIhXqaR1qMXfP3_NayTrWuKyNElTk2-6U6HyNVKewuXJ-4vjReh7NYQFZ7IL0Q0SqAqMZmmaK6qjhKtIKXxSKS8Zx3NwhM4glaZMEmW4VEXCTZ5rgz5KwjR7Brt1U-sXQBJBDRILWaDQSDyhq5zLohB5HONQbgKIh-3JCl_I3PbT-JoNiLWrzC_SNtkUGeUZ7moA0w3bylXyuI1BDHufDWmqqFgztDW3MaYbxhuy_C-sBzeEbJwpnozjNI4C2B-kLvPaps1saJnaTgEygLeb16gnbPBH1bpZWxpXucnSvNlGI5lEF55vpxCpBQOIOIDnTuLHCYoEjxJSvvz_xb-C-_0FVw-y3Ifd7vtav0aXr8sP_C_9B9dGV08
  priority: 102
  providerName: Elsevier
Title Heterogeneity of case definitions used in vaccine effectiveness studies—And its impact on meta-analysis
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0264410X06006025
https://dx.doi.org/10.1016/j.vaccine.2006.05.038
https://www.ncbi.nlm.nih.gov/pubmed/16797799
https://www.proquest.com/docview/1559079469
https://www.proquest.com/docview/1500776769
https://www.proquest.com/docview/19390545
https://www.proquest.com/docview/68144064
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfYJhASQlC-AqMYCe1p7rLEH_ETKtOmAlpVoQ31LXIcW2zakkJapL3wt3OOnUZIlPHSRumd5NSXu9_5vhB6x11Bo4lTUqpYEVqKlBRWU2ITsBUCMIRR7kD_dMon5_TTnM3DgVsT0io7ndgq6rLW7oz8wIXPYtcNXb5ffCduapSLroYRGltox7UucyldYi76FI-0HewBbgYl9DCe9xU8B5ejn0q70HWIR7BR7EpU_m6bHixUA_-Y9aMuNmPR1iadPEIPA5jEY7_7j9EdUw3QXT9e8maA7p2GwPkA7c18i-qbfXzWV1w1-3gPz_rm1cAz-OryY9oiXdyxP0HfJu5uDcJmALXj2mIN1g-Xxl5UPucLrxpT4osKhwfGPlEk6FLc-HRFQsYVUC0b7KszcV3ha7NURIXeKE_R-cnx2dGEhBkNRLNULgnAHw4qwJo0ywoVm0QwlSgFVypjZcrA_00ABMbSlkIoy6TSgtmiMBawiUhN-gxtV3VlXiAseGyBmEsNwiLBM1cFk1rzglK4VdgI0W53ch0amLs5Gld5l6l2mYdndMM1eR6zHDY1QqM128J38LiNgXdbn3flqaBQc7AxtzFma8aAXzwu-R_W4R8y1q8UPGKa0SRCu53Q5UHLNHn_TkTo7fpn0A8u6KMqU68cje_Y5GjebKKRqQTozjZT8MwlAXAaoede4PsFcgEuhJQv_73AV-h-e3jVJlDuou3lj5V5DXBuWQzR1ujX4bB9c-EzO4LrnfHHz5MpfH84ns6-_AblGk9E
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1db9Mw8DQ68SEhBOWrMDYjwZ7mLiR2Ej8gNGBTx9aqQtvUt-AkttgESSEtqH-K38g5dhohUcbL3qLkLrJ15_vwfQG8CE1Bo_ICmktPUpZHAU11xqj2UVdEaEMoaS70h6NwcMo-TPhkDX41tTAmrbKRibWgzsvM3JHvmvCZZ7qhizfTb9RMjTLR1WaEhmWLI7X4iS5b9frwPdL3pe8f7J-8G1A3VYBmPBAzigo7RKbVKojjVHrKj7j0pcQnGfM84Oix-Wi2eELnUSQ1FzKLuE5TpVGbRoEK8L_XYJ0F6Mp0YP3t_mj8sU0qCepRIujYMMpeeZO2Zmj3ov9DZiZY7iIgvO-Zopi_a8PbU1khjbQdrrHa-q214MFduOPMV7Jn-e0erKmiC9ftQMtFF24MXai-C9tj2xR7sUNO2hqvaodsk3HbLhtxumcmI6cuCyYN-n34PDBvS2RvhX4CKTXJUN-SXOnzwmaZkXmlcnJeELdhYlNTnPQmlU2QpHSvQKhZRWw9KCkL8lXNJJWuG8sDOL0S-j2ETlEW6jGQKPQ0AociQ_YUcRzLlIssC1PG8FWqe8Aa6iSZa5luJnd8SZrcuIvE7dGM8wwTjydI1B70l2hT2zPkMoSwIX3SFMSiCE9Qq12GGC8RncVkLaH_Qd38g8falaIPzmLm92CjYbrEybUqaU9hD54vP6NEMmEmWahybmBsjygDs7UKRgQCnQW-GiKMTdpByHrwyDJ8u8AwQqdFiCf_XuAW3BycDI-T48PR0VO4VV-d1embG9CZfZ-rZ2hMztJNd4IJfLpqofEbVJaIhA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1db9Mw8DSGmJAQgvJVGJuRYE9zmyX-SB4QmhhVx9i0hw31LTiJLTZBUkgL6l_j13GOnUZIlPGytyi5i2zd-T58XwAvhS1o1EFECxUoygoZ0czkjJoQdYVEG0Ire6F_fCLG5-z9hE_W4FdbC2PTKluZ2AjqosrtHfnQhs8C2w09GRqfFnF6MHoz_UbtBCkbaW3HaTgWOdKLn-i-1a8PD5DWr8Jw9O7s7Zj6CQM051Eyo6i8BTKw0VEcZyrQoeQqVAqfVMyLiKP3FqIJEySmkFIZnqhccpNl2qBmlZGO8L834KaM-J49Y3Iiu_SSqBkqgi4Oo2wvmHTVQ8PLwQ-V27C5j4XwQWDLY_6uF-9MVY3UMm7Mxmo7uNGHo3tw1xuyZN9x3n1Y02UPbrnRlosebBz7oH0Pdk5de-zFLjnrqr3qXbJDTrvG2YjT-2hzc5oCYdKiP4DPY_u2QkbX6DGQypAcNS8ptLkoXb4Zmde6IBcl8RsmLknFy3FSu1RJSvdLhJrVxFWGkqokX_VMUeX7sjyE82uh3iNYL6tSPwEiRWAQWCQ5MmoSx7HKeJLnImMMX2WmD6ylTpr75ul2hseXtM2Su0z9Hu1gT5EGPEWi9mGwRJu67iFXIYiW9GlbGovCPEX9dhVivET0tpOzif4HdesPHutWit44i1nYh82W6VIv4eq0O499eLH8jLLJBpxUqau5hXHdoizM9iqYJErQbeCrIURsExAE68Njx_DdAoVE9yVJnv57gduwgaIi_XB4cvQMbjd3aE0e5yasz77P9XO0KmfZVnN8CXy6bnnxGxEHi1Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Heterogeneity+of+case+definitions+used+in+vaccine+effectiveness+studies%E2%80%94And+its+impact+on+meta-analysis&rft.jtitle=Vaccine&rft.au=Beyer%2C+Walter+E.P.&rft.date=2006-11-10&rft.issn=0264-410X&rft.volume=24&rft.issue=44-46&rft.spage=6602&rft.epage=6604&rft_id=info:doi/10.1016%2Fj.vaccine.2006.05.038&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_vaccine_2006_05_038
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0264-410X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0264-410X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0264-410X&client=summon